IPO Premiums
IPO calendar
GLListed

Glenmark Life Sciences Limited

Bookbuilding IPO · NSE, BSE

Price band
₹695-₹720
Lot size
20 shares
Issue amount
₹1,514 cr
Total subscription
0×
Current price₹1,268.6
Listing price ₹750
Watch live price ↗
Opens
27 Jul 2021
Closes
29 Jul 2021
Allotment
3 Aug 2021
Listing
6 Aug 2021

Offer at a glance

Issue overview

Issue size
2,10,22,222 shares
Face value
₹2 per share
Minimum investment
₹13,900
Fresh issue
₹1,060 cr
Offer for sale
₹454 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,400
Issue type
Bookbuilding IPO
Shares before issue
10,78,04,950
Shares after issue
12,25,27,172

Lot sizes

CategoryLotsSharesAmount
RETAIL120₹14,400
sHNI13280₹2,01,600
bHNI701,400₹10,08,000

Share reservation

QIB50%
Anchor30%
NII (HNI)15%
RETAIL35%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

0418223 Dec: ₹82
23 Dec₹8223 Dec

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
05,00010,00015,00020,000Mar-19 · Revenue: 8,868.65Mar-19 · Profit after tax: 1,955.92Mar-19Mar-20 · Revenue: 15,493.03Mar-20 · Profit after tax: 3,130.98Mar-20Mar-21 · Revenue: 18,859.76Mar-21 · Profit after tax: 3,515.81Mar-21
RevenueProfit after tax

Company information

Company profile

Incorporated in 2011, Glenmark Life Sciences is a leading manufacturer of active pharmaceutical ingredients (APIs), developing and supplying high-quality products used in treatments for cardiovascular, central nervous system, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. The company serves customers in India and exports its products to several international markets including Europe, North America, Latin America, and Japan. It operates four manufacturing facilities located at Ankleshwar and Dahej in Gujarat, and Mohol and Kurkumbh in Maharashtra, with a total annual installed capacity of 725.8 KL as of December 31, 2020.

Strengths

  • Leading API Manufacturer: Specializes in APIs for chronic therapies like CVS, CNS, diabetes, and pain management.
  • Global Exports: Supplies products across Europe, Latin America, North America, Japan, and other regions.
  • Strong Global Relationships: Works closely with leading generic pharmaceutical companies worldwide.
  • Strong Financials: Proven track record of consistent financial performance.
  • Quality & R&D Focus: High-quality manufacturing supported by robust R&D infrastructure.

Promoters

Glenmark Pharmaceuticals Limited

Registrar & documents

Lead manager

Bofa Securities India Limited, Bob Capital Markets Limited, Dam Capital Advisors Limited, Goldman Sachs (India) Securities Private Limited, Kotak Mahindra Capital Company Limited, SBI Capital Markets Limited

Registered office

Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213,

+91 2189 234456

[email protected]Company website ↗

Frequently Asked Questions

What is Glenmark Life Sciences IPO GMP today?

As of today, Glenmark Life Sciences IPO Grey Market Premium (GMP) is reported at +₹82 per share. Based on the upper price band of ₹720, the estimated listing price is ₹802 (+11.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Glenmark Life Sciences IPO?

The minimum bid lot size for Glenmark Life Sciences IPO is 20 shares. At the cut-off price of ₹720 per share, retail investors need a minimum application amount of ₹14,400 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Glenmark Life Sciences IPO allotment status be announced?

The allotment status for Glenmark Life Sciences IPO is scheduled to be finalized on 3 Aug 2021. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Glenmark Life Sciences IPO allotment status online by PAN?

To check Glenmark Life Sciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Glenmark Life Sciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Glenmark Life Sciences IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums